Acquires Regulus Therapeutics for $1.7 Billion

finance.yahoo.com/news/novartis-nvs-acquires-regulus-therapeutics-163917740.html

In This Article:
Novartis AG (NYSE:NVS) is one of the 11 best European stocks to invest in. On June 23, the company confirmed it had completed the acquisition of Regulus Therapeutics. Following the acquisition, the shares of Regulus ceased trading on the NASDAQ exchange, and the company…

This story appeared on finance.yahoo.com, 2025-06-28 16:39:17.
The Entire Business World on a Single Page. Free to Use →